Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geron Corp
(NQ:
GERN
)
4.110
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Geron Corp
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Geron Announces Positive Top-Line Results from IMerge Phase 3 Trial of Imetelstat in Lower Risk MDS
January 04, 2023
From
Geron Corporation
Via
Business Wire
Geron Announces Conference Call for Top-Line Results from IMerge Phase 3
January 03, 2023
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 22, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Oral Presentation at ASH Annual Meeting Highlighting Continuous Long-Term Transfusion Independence with Imetelstat Treatment in Lower Risk MDS Patients
December 12, 2022
From
Geron Corporation
Via
Business Wire
Geron (GERN) Q3 2022 Earnings Call Transcript
November 04, 2022
GERN earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2022
From
Geron Corporation
Via
Business Wire
Geron to Participate in Stifel 2022 Healthcare Conference
November 07, 2022
From
Geron Corporation
Via
Business Wire
Geron Announces Presentations at Upcoming ASH Annual Meeting Including Long-term Phase 2 Data Showing Continuous Durable Transfusion Independence in Patients with Lower Risk MDS
November 03, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones
November 03, 2022
From
Geron Corporation
Via
Business Wire
Recap: Geron Q2 Earnings
August 11, 2022
Geron (NASDAQ:GERN) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Preview: Geron
November 02, 2022
Geron (NASDAQ:GERN) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Geron will report an...
Via
Benzinga
10 Best Medical Stocks Under $5
October 29, 2022
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
October 28, 2022
Upgrades
Via
Benzinga
Geron to Announce Third Quarter 2022 Financial Results on November 3, 2022
October 27, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 20, 2022
From
Geron Corporation
Via
Business Wire
Marathon Digital, Coinbase Global And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
September 27, 2022
U.S. stock futures traded higher this morning after recording losses in the previous session. Here are some big stocks moving higher in today’s pre-market trading session.
Via
Benzinga
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
September 27, 2022
Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for...
Via
Benzinga
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 22, 2022
From
Geron Corporation
Via
Business Wire
H.B. Fuller, Lennar And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
September 22, 2022
U.S. stock futures traded slightly higher this morning after recording losses in the previous session. Here are some big stocks moving higher in today’s pre-market trading session.
Via
Benzinga
7 Top-Rated Biotech Stocks to Buy for Q4
September 15, 2022
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
September 13, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors
September 08, 2022
From
Geron Corporation
Via
Business Wire
Geron's Return On Capital Employed Insights
September 06, 2022
According to data from Benzinga Pro, during Q2, Geron's (NASDAQ:GERN) reported sales totaled $73 thousand. Despite a 6.58% increase in earnings, the company posted a loss of $28.12 million.
Via
Benzinga
Geron to Present at Upcoming Investor Conferences
September 01, 2022
From
Geron Corporation
Via
Business Wire
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
Via
Benzinga
Geron Commences Initial-Stage Rare Blood Cancer Combination Study
August 22, 2022
Geron Corporation (NASDAQ: GERN) has dosed first patient in IMproveMF study evaluating imetelstat in combination with ruxolitinib for patients with frontline myelofibrosis (MF).
Via
Benzinga
Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis
August 22, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2022
From
Geron Corporation
Via
Business Wire
Cowen Slashes Price Target On This Stock By Over 78%; Also Check Out Some Other Big PT Changes
August 12, 2022
Cowen & Co. cut the price target for The RealReal, Inc. (NASDAQ: REAL) from $14 to $3. RealReal shares fell 0.7% to $3.1388 in pre-market trading.
Via
Benzinga
Geron Corporation Reports Second Quarter 2022 Financial Results
August 11, 2022
From
Geron Corporation
Via
Business Wire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.